Radiolabelled Interleukin-2 for the study of vulnerable carotid plaque in patients with long-term statin treatment: a pilot study.

Radiolabelled Interleukin-2 for the study of vulnerable carotid plaque in patients with long-term statin treatment: a pilot study. - RITS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32239

Enrollment

Registered

2008-09-10

Start date

2010-07-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular disease stroke

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Scheduled carotis endartiectomy More than 3 months on statin therapy

Exclusion criteria

Exclusion criteria: pregnancy

Design outcomes

Primary

Measure	Time frame
Uptake value of radio-active IL-2	—

Secondary

Measure	Time frame
Comparison between SPECT and IP-guardian camera	—

Countries

Netherlands

Outcome results